You are here

olaparib

AZ/Merck & Co reveal data supporting PARP drug in prostate cancer

Pharmaforum

Sat, 06/1/19 - 12:43 pm

prostate cancer

AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US

Yahoo

Wed, 03/29/17 - 09:05 am

LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer

Yahoo

Mon, 06/6/16 - 10:31 am

AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients

Fierce Biotech

Fri, 10/30/15 - 11:17 am

prostate cancer

AZ's Soriot lashes out at U.K.'s refusal to pay for first-in-class cancer drug

Fierce Pharma

Wed, 06/3/15 - 11:35 am

AstraZeneca first-in-class ovarian cancer drug wins EU approval

Yahoo/Reuters

Thu, 12/18/14 - 09:01 am

AstraZeneca ovarian cancer drug wins European green light

Yahoo/Reuters

Fri, 10/24/14 - 07:31 am

AstraZeneca looks to EU decision for next cancer drug boost

Yahoo/Reuters

Tue, 10/14/14 - 09:48 am

Cancer drug setback tarnishes AstraZeneca's R&D claims

Yahoo/Reuters

Thu, 06/26/14 - 09:34 am

FDA panel votes for more data before approval of AstraZeneca drug

Yahoo/Reuters

Wed, 06/25/14 - 03:22 pm

advisory panels

AstraZeneca Gets a Chance to Prove Its Worth to Pfizer

Motley Fool

Tue, 06/24/14 - 04:33 pm

FDA staff question validity of benefit seen with AstraZeneca drug

Yahoo/Reuters

Mon, 06/23/14 - 09:42 am

Two experimental AstraZeneca drugs show promise in ovarian cancer

Yahoo/Reuters

Sat, 05/31/14 - 10:26 am

AstraZeneca reverses $285 mln charge as cancer trial starts

Reuters

Wed, 09/4/13 - 09:19 am

Olaparib in Patients With BRCA Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer: New Data Presented at ASCO

Yahoo/BusinessWire

Sat, 06/1/13 - 12:25 pm

AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials

Bloomberg

Thu, 05/16/13 - 10:33 am

moxetumomab pasudotox

hairy cell leukemia

non-small cell lung cancer

AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well

Yahoo/AP

Tue, 12/20/11 - 10:50 am

antidepressants

AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer

Bloomberg

Wed, 05/18/11 - 06:37 pm